Showing results (11-20 of 425) with videos related to
Sort By:
Pageof 43
American Heart Journal|June 23, 2009
Atrial fibrillation and quality of life after pacemaker implantation for sick sinus syndrome: data from the Mode Selection Trial (MOST)Kirsten E Fleischmann, E John Orav, Gervasio A Lamas, et al.Current Cardiology Reports|January 23, 2016
Edetate Disodium-Based Treatment for Secondary Prevention in Post-Myocardial Infarction PatientsGervasio A Lamas, Omar M IssaHeart (British Cardiac Society)|October 16, 2007
Where does the Occluded Artery Trial leave the late open artery hypothesis?Gervasio A Lamas, Judith S HochmanAmerican Heart Journal|December 17, 2011
Design of the Trial to Assess Chelation Therapy (TACT)Gervasio A Lamas, Christine Goertz, Robin Boineau, et al.Circulation|June 5, 2003
Adverse effect of ventricular pacing on heart failure and atrial fibrillation among patients with normal baseline QRS duration in a clinical trial of pacemaker therapy for sinus node dysfunctionMichael O Sweeney, Anne S Hellkamp, Kenneth A Ellenbogen, et al.Heart Rhythm|April 27, 2005
Heart failure hospitalization is more common in pacemaker patients with sinus node dysfunction and a prolonged paced QRS durationHimanshu H Shukla, Anne S Hellkamp, Erskine A James, et al.Journal of Cardiovascular Electrophysiology|March 19, 2004
Prospective randomized study of mode switching in a clinical trial of pacemaker therapy for sinus node dysfunctionMichael O Sweeney, Anne S Hellkamp, Kenneth A Ellenbogen, et al.Pacing and Clinical Electrophysiology : PACE|August 18, 2005
Clinical and quality of life comparison of accelerometer, piezoelectric crystal, and blended sensors in DDDR-paced patients with sinus node dysfunction in the mode selection trial (MOST)Himanshu H Shukla, Greg C Flaker, Anne S Hellkamp, et al.Circulation|January 5, 2005
Cost-effectiveness of dual-chamber pacing compared with ventricular pacing for sinus node dysfunctionStéphane Rinfret, David J Cohen, Gervasio A Lamas, et al.Current Atherosclerosis Reports|November 9, 2016
Chronic Toxic Metal Exposure and Cardiovascular Disease: Mechanisms of Risk and Emerging Role of Chelation TherapyEhimen C Aneni, Esteban Escolar, Gervasio A LamasPageof 43